Türkiye's pioneering industrial enzyme producer Livzym Biotechnologies announced it secured an investment from global fermentation leader Lallemand Inc. through its Swiss affiliate Danstar Ferment AG.
Founded in 2014, Livzym specializes in producing sustainable, fungal-based industrial enzymes used across various industries, including food, textiles, paper, animal feed, and biofuels. These enzymes are crucial for reducing energy and resource consumption in chemical processes and industrial applications, significantly minimizing environmental impacts. The company serves a broad customer base across Europe, Asia, the Middle East, and Africa.
Livzym Founder and CEO Dr. Serdar Uysal emphasized the importance of biotechnology in global sustainability. “The future of food and agriculture is critical for global sustainability, with biotechnology playing a key role in transforming production technologies. As Türkiye's first industrial enzyme producer, Livzym enables us to serve customers across Europe, Asia, the Middle East, and Africa," he said. Uysal expressed enthusiasm about the strategic investment partnership with Lallemand, viewing it as a significant opportunity to advance sustainability and enzyme and alternative protein technologies through Livzym's precision fermentation capabilities.
Lallemand Bio-Ingredients President Lars Asferg commented on the collaboration, stating, “The strategic partnership with Livzym and their fungal development and production platform perfectly complements our position in the enzyme sector." Asferg believes that incorporating Livzym's enzymes into Lallemand's portfolio will allow them to offer customers a new range of high-performance enzymes.
Lallemand is a family-owned business headquartered in Canada, specializing in the development, production, and marketing of yeast, bacteria, fungi, and enzyme-based solutions across various sectors. These include baking, food ingredients, human and animal nutrition and health, biofuels and distilled spirits, crop protection and nutrition, oenology, and brewing. Lallemand operates in more than 50 countries, with over 50 production plants and approximately 5,500 employees.
This strategic investment marks a significant milestone for Livzym Biotechnologies, poised to enhance its capacity for innovation and expand its reach in the industrial enzyme market.